Is It Possible to Use Avacopan Alone in the Induction of Remission in ANCA-associated Vasculitis?
Overview
Overview
Journal
Rheumatol Adv Pract
Publisher
Oxford University Press
Specialty
Rheumatology
Date
2024 Sep 5
PMID
39233788
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Geetha D, Dua A, Yue H, Springer J, Salvarani C, Jayne D
. Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial. Ann Rheum Dis. 2023; 83(2):223-232.
PMC: 10850685.
DOI: 10.1136/ard-2023-224816.
View
2.
Jayne D, Merkel P, Schall T, Bekker P
. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021; 384(7):599-609.
DOI: 10.1056/NEJMoa2023386.
View
3.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K
. Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial. JAMA. 2021; 325(21):2178-2187.
PMC: 8170547.
DOI: 10.1001/jama.2021.6615.
View
4.
Jayne D
. Complement inhibition in ANCA vasculitis. Nephrol Ther. 2019; 15(6):409-412.
DOI: 10.1016/j.nephro.2019.04.001.
View
5.
Shiratori-Aso S, Nakazawa D
. The involvement of NETs in ANCA-associated vasculitis. Front Immunol. 2023; 14:1261151.
PMC: 10539550.
DOI: 10.3389/fimmu.2023.1261151.
View